JW Lifescience Corporation (KRX:234080)
South Korea
· Delayed Price · Currency is KRW 13,100
0.00 (0.00%)
Apr 29, 2026, 3:30 PM KST
JW Lifescience Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 202,848 | 198,977 | 168,472 | 199,286 | 188,137 | 214,461 | Upgrade
|
| Market Cap Growth | 18.66% | 18.11% | -15.46% | 5.93% | -12.27% | -34.73% | Upgrade
|
| Enterprise Value | 242,931 | 222,030 | 157,490 | 227,270 | 221,603 | 261,011 | Upgrade
|
| Last Close Price | 13100.00 | 12315.80 | 10427.69 | 11792.53 | 10711.11 | 11730.97 | Upgrade
|
| PE Ratio | 7.09 | 6.96 | 3.83 | 7.08 | 12.58 | 16.61 | Upgrade
|
| Forward PE | - | 9.92 | 9.92 | 9.92 | 9.92 | 9.92 | Upgrade
|
| PS Ratio | 0.79 | 0.77 | 0.76 | 0.96 | 1.00 | 1.26 | Upgrade
|
| PB Ratio | 0.92 | 0.90 | 0.84 | 1.25 | 1.34 | 1.63 | Upgrade
|
| P/TBV Ratio | 1.41 | 1.39 | 1.37 | 1.28 | 1.38 | 1.69 | Upgrade
|
| P/FCF Ratio | 7.25 | 7.11 | 4.17 | 6.77 | 31.10 | 19.17 | Upgrade
|
| P/OCF Ratio | 5.00 | 4.91 | 3.32 | 5.30 | 13.32 | 7.11 | Upgrade
|
| EV/Sales Ratio | 0.94 | 0.86 | 0.71 | 1.10 | 1.17 | 1.54 | Upgrade
|
| EV/EBITDA Ratio | 4.72 | 4.32 | 3.05 | 4.90 | 5.27 | 6.27 | Upgrade
|
| EV/EBIT Ratio | 7.31 | 6.68 | 4.39 | 7.36 | 8.18 | 9.19 | Upgrade
|
| EV/FCF Ratio | 8.68 | 7.94 | 3.90 | 7.73 | 36.63 | 23.33 | Upgrade
|
| Debt / Equity Ratio | 0.23 | 0.23 | 0.35 | 0.29 | 0.48 | 0.35 | Upgrade
|
| Debt / EBITDA Ratio | 0.98 | 0.98 | 1.34 | 1.00 | 1.60 | 1.12 | Upgrade
|
| Debt / FCF Ratio | 1.81 | 1.81 | 1.72 | 1.57 | 11.11 | 4.16 | Upgrade
|
| Net Debt / Equity Ratio | 0.18 | 0.18 | 0.30 | 0.11 | 0.27 | 0.32 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.78 | 0.78 | 1.16 | 0.39 | 0.91 | 0.99 | Upgrade
|
| Net Debt / FCF Ratio | 1.43 | 1.43 | 1.48 | 0.61 | 6.34 | 3.70 | Upgrade
|
| Asset Turnover | 0.80 | 0.80 | 0.77 | 0.81 | 0.80 | 0.78 | Upgrade
|
| Inventory Turnover | 5.53 | 5.53 | 5.61 | 6.80 | 6.54 | 6.38 | Upgrade
|
| Quick Ratio | 0.66 | 0.66 | 0.87 | 0.89 | 1.03 | 0.45 | Upgrade
|
| Current Ratio | 1.05 | 1.05 | 1.32 | 1.14 | 1.31 | 0.77 | Upgrade
|
| Return on Equity (ROE) | 13.59% | 13.59% | 24.45% | 18.78% | 11.01% | 9.78% | Upgrade
|
| Return on Assets (ROA) | 6.46% | 6.46% | 7.71% | 7.58% | 7.17% | 8.19% | Upgrade
|
| Return on Invested Capital (ROIC) | 12.02% | 11.51% | 12.22% | 14.48% | 11.09% | 11.83% | Upgrade
|
| Return on Capital Employed (ROCE) | 14.20% | 14.20% | 14.60% | 19.10% | 15.70% | 21.00% | Upgrade
|
| Earnings Yield | 14.10% | 14.38% | 26.11% | 14.12% | 7.95% | 6.02% | Upgrade
|
| FCF Yield | 13.79% | 14.06% | 23.97% | 14.76% | 3.21% | 5.22% | Upgrade
|
| Dividend Yield | 3.86% | - | - | 4.24% | 4.67% | 4.26% | Upgrade
|
| Payout Ratio | 27.07% | 27.07% | 17.60% | 27.51% | 51.75% | 61.31% | Upgrade
|
| Buyback Yield / Dilution | -0.03% | -0.03% | 0.01% | - | 0.61% | 1.61% | Upgrade
|
| Total Shareholder Return | 3.83% | -0.03% | 0.01% | 4.24% | 5.28% | 5.87% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.